CODX vs UTHR · rev $3.9M vs P/E 20, rev $2.88B
Co-Diagnostics, Inc. Common Stock (CODX) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
CODX currently screens at market cap $31.4M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the CODX and UTHR stock pages for the full models.
Not investment advice.